UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Congrès l’association américaine de recherche contre le cancer — AACR 2017

Oncologie (Paris, France), 2017-07, Vol.19 (7-8), p.209-230

2017

Volltextzugriff (PDF)

Patients’ selection and trial matching in early-phase oncology clinical trials

Critical reviews in oncology/hematology, 2024-04, Vol.196, p.104307-104307, Article 104307

2024

Volltextzugriff (PDF)

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

Annals of oncology, 2021-12, Vol.32 (12), p.1642-1645

2021

Volltextzugriff (PDF)

PREDMED®, a normalized expression signature of drug targets versus reference tissues aiming at generalizing treatment personalization

Annals of oncology, 2018-09, Vol.29, p.vi9-vi9

2018

Volltextzugriff (PDF)

Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial

Annals of oncology, 2018-10, Vol.29, p.viii653-viii654

2018

Volltextzugriff (PDF)

PREDMED® TEST, new normalized expression method to predict the effect of tumor- and microenvironment-targeted therapies

Annals of oncology, 2017-10, Vol.28, p.vii5-vii5

2017

Volltextzugriff (PDF)

Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial

Annals of oncology, 2018-10, Vol.29, p.viii667-viii667

2018

Volltextzugriff (PDF)

Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

Annals of oncology, 2018-10, Vol.29, p.viii378-viii379

2018

Volltextzugriff (PDF)

Molecular profile characterization and impact on clinical outcome in metastatic NSCLC patients enrolled in MOSCATO 01 trial

Annals of oncology, 2017-10, Vol.28, p.vi55-vi55

2017

Volltextzugriff (PDF)

120P A prospective comparative evaluation of automatic trial match tools in a molecular tumor board

Annals of oncology, 2024-09, Vol.35, p.S262-S262

2024

Volltextzugriff (PDF)

703P Prognostic scores for immunotherapy-based phase one trials (P1T): To GRIm or not to GRIm?

Annals of oncology, 2023-10, Vol.34, p.S488-S488

2023

Volltextzugriff (PDF)

654P Peripheral neuropathy (PN) following treatment (tx) with bicycle toxin conjugates (BTCs) BT8009 or BT5528 monotherapy in patients (pts) with advanced solid tumors

Annals of oncology, 2024-09, Vol.35, p.S517-S517

2024

Volltextzugriff (PDF)

PCN431 EFFICACY PREDICTION IN PHASE I ONCOLOGY CLINICAL TRIALS USING DEEP LEARNING

Value in health, 2019-11, Vol.22, p.S519-S520

2019

Volltextzugriff (PDF)

197P PRIME-ROSE: Merging clinical outcome data from DRUP-like clinical trials

Annals of oncology, 2024-09, Vol.35, p.S294-S295

2024

Volltextzugriff (PDF)

694P Full efficacy analysis of phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy in refractory solid tumors

Annals of oncology, 2023-10, Vol.34, p.S483-S484

2023

Volltextzugriff (PDF)

652P BT8009 monotherapy in enfortumab vedotin (EV)-naïve patients (pts) with metastatic urothelial carcinoma (mUC): Updated results of Duravelo-1

Annals of oncology, 2024-09, Vol.35, p.S515-S516

2024

Volltextzugriff (PDF)

165PEnhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Annals of oncology, 2019-10, Vol.30, p.v52

2019

Volltextzugriff (PDF)

165P - Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Annals of oncology, 2019-10, Vol.30, p.v52-v52

2019

Volltextzugriff (PDF)

9P Predictive factors and profiles of tumour response to epigenetic drugs in phase I trials

Annals of oncology, 2021-03, Vol.32, p.S5-S5

2021

Volltextzugriff (PDF)

70P Genomic landscape and efficacy of precision medicine in biliary tract cancers

Annals of oncology, 2020-09, Vol.31, p.S267-S268

2020

Volltextzugriff (PDF)

1563P Early clinical trials in patients with pancreatic cancer: Assessment of factors limiting eligibility and effectiveness

Annals of oncology, 2020-09, Vol.31, p.S953-S953

2020

Volltextzugriff (PDF)

Évolution épidémiologique du cancer broncho-pulmonaire en France et en Europe

Revue des maladies respiratoires actualités, 2013-09, Vol.5 (5), p.321-324

2013

Volltextzugriff (PDF)

711P Outcomes according to genomic characteristics of patients with metastatic urothelial carcinoma in phase I/II trials

Annals of oncology, 2021-09, Vol.32, p.S718-S719

2021

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Englisch
(64)
Französisch
(32)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Congrès l’association américaine de recherche contre le cancer — AACR 2017

Patients’ selection and trial matching in early-phase oncology clinical trials

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

PREDMED®, a normalized expression signature of drug targets versus reference tissues aiming at generalizing treatment personalization

Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial

PREDMED® TEST, new normalized expression method to predict the effect of tumor- and microenvironment-targeted therapies

Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial

Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

Molecular profile characterization and impact on clinical outcome in metastatic NSCLC patients enrolled in MOSCATO 01 trial

120P A prospective comparative evaluation of automatic trial match tools in a molecular tumor board

703P Prognostic scores for immunotherapy-based phase one trials (P1T): To GRIm or not to GRIm?

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

654P Peripheral neuropathy (PN) following treatment (tx) with bicycle toxin conjugates (BTCs) BT8009 or BT5528 monotherapy in patients (pts) with advanced solid tumors

PCN431 EFFICACY PREDICTION IN PHASE I ONCOLOGY CLINICAL TRIALS USING DEEP LEARNING

197P PRIME-ROSE: Merging clinical outcome data from DRUP-like clinical trials

694P Full efficacy analysis of phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy in refractory solid tumors

652P BT8009 monotherapy in enfortumab vedotin (EV)-naïve patients (pts) with metastatic urothelial carcinoma (mUC): Updated results of Duravelo-1

165PEnhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

165P - Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

9P Predictive factors and profiles of tumour response to epigenetic drugs in phase I trials

70P Genomic landscape and efficacy of precision medicine in biliary tract cancers

1563P Early clinical trials in patients with pancreatic cancer: Assessment of factors limiting eligibility and effectiveness

Évolution épidémiologique du cancer broncho-pulmonaire en France et en Europe

711P Outcomes according to genomic characteristics of patients with metastatic urothelial carcinoma in phase I/II trials

Suchergebnisse filtern